These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8630663)

  • 21. Association of sex hormones and adiposity with plasma levels of fibrinogen and PAI-1 in postmenopausal women.
    Meilahn EN; Cauley JA; Tracy RP; Macy EO; Gutai JP; Kuller LH
    Am J Epidemiol; 1996 Jan; 143(2):159-66. PubMed ID: 8546117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increase in both pro-thrombotic and anti-thrombotic factors in obese premenopausal women: relationship with body fat distribution.
    De Pergola G; De Mitrio V; Giorgino F; Sciaraffia M; Minenna A; Di Bari L; Pannacciulli N; Giorgino R
    Int J Obes Relat Metab Disord; 1997 Jul; 21(7):527-535. PubMed ID: 9226481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) in diabetic foot syndrome.
    Kulwas A; Lisewska B; Jundziłł W; Ruszkowska B; Drewniak W; Ruprecht Z; Gadomska G; Rość D
    Adv Med Sci; 2017 Mar; 62(1):87-91. PubMed ID: 28193577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism.
    Chadarevian R; Bruckert E; Leenhardt L; Giral P; Ankri A; Turpin G
    J Clin Endocrinol Metab; 2001 Feb; 86(2):732-7. PubMed ID: 11158038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute paraquat intoxication.
    Seok SJ; Kim SJ; Gil HW; Yang JO; Lee EY; Hong SY
    J Korean Med Sci; 2011 Apr; 26(4):474-81. PubMed ID: 21468253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome.
    Andersen P; Seljeflot I; Abdelnoor M; Arnesen H; Dale PO; Løvik A; Birkeland K
    Metabolism; 1995 May; 44(5):611-6. PubMed ID: 7752909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship of tissue plasminogen activator, plasminogen activator inhibitor-1 and fibrinogen with coronary artery disease in South Indian male subjects.
    Deepa R; Velmurugan K; Saravanan G; Dwarakanath V; Agarwal S; Mohan V
    J Assoc Physicians India; 2002 Jul; 50():901-6. PubMed ID: 12126344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasminogen activator inhibitor-1 and tissue-plasminogen activator in minority adolescents with type 2 diabetes and obesity.
    Umpaichitra V; Hussain MM; Castells S
    Pediatr Res; 2005 Sep; 58(3):483-7. PubMed ID: 15901895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Absence of profound hyperinsulinism in polycystic ovary syndrome is associated with subtle elevations in the plasminogen activator inhibitor system.
    Sills ES; Drews CD; Perloe M; Tucker MJ; Kaplan CR; Palermo GD
    Gynecol Endocrinol; 2003 Jun; 17(3):231-7. PubMed ID: 12857431
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of estrogen and angiotensin-converting enzyme inhibition on plasminogen activator inhibitor-1 in healthy postmenopausal women.
    Brown NJ; Abbas A; Byrne D; Schoenhard JA; Vaughan DE
    Circulation; 2002 Jan; 105(3):304-9. PubMed ID: 11804984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents.
    Sudi KM; Gallistl S; Weinhandl G; Muntean W; Borkenstein MH
    Metabolism; 2000 Jul; 49(7):890-5. PubMed ID: 10910001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do plasminogen activator inhibitor (PAI-1) or tissue plasminogen activator PAI-1 complexes predict complications in Type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications Study.
    Bosnyak Z; Forrest KY; Maser RE; Becker D; Orchard TJ;
    Diabet Med; 2003 Feb; 20(2):147-51. PubMed ID: 12581266
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Beneficial effect of a moderately energy-restricted diet on fibrinolytic factors in non-obese men.
    Velthuis-te Wierik EJ; Meijer P; Kluft C; van den Berg H
    Metabolism; 1995 Dec; 44(12):1548-52. PubMed ID: 8786722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased levels of tPA antigen and tPA/PAI-1 complex in myotonic dystrophy.
    Johansson A; Boman K; Cederquist K; Forsberg H; Olsson T
    J Intern Med; 2001 Jun; 249(6):503-10. PubMed ID: 11422656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute psychological stress decreases plasma tissue plasminogen activator (tPA) and tissue plasminogen activator/plasminogen activator inhibitor-1 (tPA/PAI-1) complexes in cardiac patients.
    Hevey D; McGee HM; Fitzgerald D; Horgan JH
    Eur J Appl Physiol; 2000 Nov; 83(4 -5):344-8. PubMed ID: 11138573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ACE inhibition versus angiotensin type 1 receptor antagonism: differential effects on PAI-1 over time.
    Brown NJ; Kumar S; Painter CA; Vaughan DE
    Hypertension; 2002 Dec; 40(6):859-65. PubMed ID: 12468570
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Caffeine Augments the Prothrombotic but Not the Fibrinolytic Response to Exercise.
    Nagelkirk PR; Sackett JR; Aiello JJ; Fitzgerald LF; Saunders MJ; Hargens TA; Womack CJ
    Med Sci Sports Exerc; 2019 Mar; 51(3):421-425. PubMed ID: 30395052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haemostasis in relation to dietary fat as estimated by erythrocyte fatty acid composition: the prime study.
    Scarabin PY; Aillaud MF; Luc G; Lacroix B; Mennen L; Amouyel P; Evans A; Ferrières J; Arveiler D; Juhan-Vague I;
    Thromb Res; 2001 May; 102(4):285-93. PubMed ID: 11369422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No influence of proinsulin and insulin on plasma levels of plasminogen activator inhibitor type 1 and tissue plasminogen activator in young women before and during intake of contraceptive steroids.
    Petersen KR; Kjems LL; Skouby SO; Andersen LF; Jespersen J
    Metabolism; 1996 Jul; 45(7):833-7. PubMed ID: 8692017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.